Platelet News and Research

RSS
Corgenix Medical issued additional U.S. patent covering AspirinWorks technology

Corgenix Medical issued additional U.S. patent covering AspirinWorks technology

Scientists discover septet of overactive genes that control bodily function

Scientists discover septet of overactive genes that control bodily function

PAS technique to predict how blood platelets respond to complex conditions found during heart attack

PAS technique to predict how blood platelets respond to complex conditions found during heart attack

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

Clinical trial to examine use of biomarkers to advance treatment of malignant gliomas launched

Clinical trial to examine use of biomarkers to advance treatment of malignant gliomas launched

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress

AMG 386 demonstrates antitumor activity in Phase 2 trial involving patients with recurrent ovarian cancer

AMG 386 demonstrates antitumor activity in Phase 2 trial involving patients with recurrent ovarian cancer

Advanced applications of Nanoflex technology to be presented at New Cardiovascular Horizons Meeting

Advanced applications of Nanoflex technology to be presented at New Cardiovascular Horizons Meeting

Platelets play important role in cerebral malaria: Research

Platelets play important role in cerebral malaria: Research

OnePath Gaucher Application available for patients with Type 1 Gaucher disease

OnePath Gaucher Application available for patients with Type 1 Gaucher disease

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Phase II study results of Lilly Oncology's tasisulam for metastatic melanoma to be presented at 46th ASCO

Phase II study results of Lilly Oncology's tasisulam for metastatic melanoma to be presented at 46th ASCO

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

IMBio receives regulatory concurrence from FDA to market OCL 500 microspheres in the U.S.

IMBio receives regulatory concurrence from FDA to market OCL 500 microspheres in the U.S.

Increased cholesterol levels can affect microenvironment of bone marrow

Increased cholesterol levels can affect microenvironment of bone marrow

Non-compliance, NSAIDs use inhibit clinical benefit of aspirin

Non-compliance, NSAIDs use inhibit clinical benefit of aspirin

Researchers present positive results of Phase II clinical trial of eliglustat tartrate

Researchers present positive results of Phase II clinical trial of eliglustat tartrate

NYBC urges community to donate blood in recognition of Mother's Day

NYBC urges community to donate blood in recognition of Mother's Day

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.